medline.ch Urologie-Nephrologie Tumoren BPH

	Recent Advancements in Prostate Catheters and Stents for Management of Benign Prostatic Hyperplasia. Curr Urol Rep Lama J, Winograd J, Codelia-Anjum A, Bhojani N, Elterman D, Zorn KC, Chughtai B. PMID: 39373947 [PubMed - indexed for MEDLINE]
	[Current developments in urothelial carcinoma]. Urologie Niegisch G, Kramer M. PMID: 39373754 [PubMed - indexed for MEDLINE]
	Pure yolk sac tumor of the testis on histopathology: a clinical image. Pan Afr Med J Kalode S, Tekulwar P. PMID: 39372696 [PubMed - indexed for MEDLINE]
	A Rare Case of Intravascular Lobular Capillary Hemangioma Mimicking a Testicular Tumor: Diagnostic Challenges. Cureus Erbagci A, Aydin A, Toksöz Y, Cobanoglu Simsek B. PMID: 39372378 [PubMed]
	Synergistic Potential of Nanomedicine in Prostate Cancer Immunotherapy: Breakthroughs and Prospects. Int J Nanomedicine Jiang Y, Wang C, Zu C, Rong X, Yu Q, Jiang J. PMID: 39371481 [PubMed - indexed for MEDLINE]
	Association between autoimmunity-related disorders and prostate cancer: A Mendelian randomization study. Cancer Pathog Ther Chen P, Wang Y, Xiong Z, Luo T, Lai Y, Zhong H, Peng S, Zhuang R, Li K, Huang H. PMID: 39371096 [PubMed]
	Clinical value of a radiomics model based on machine learning for the prediction of prostate cancer. J Int Med Res Chen ZL, Huang ZC, Lin SS, Li ZH, Dou RL, Xu Y, Jiang SQ, Li MQ. PMID: 39370971 [PubMed - indexed for MEDLINE]
	Nutrient Intakes in Prostate Cancer Survivors in the United States: A Nationally Representative Study. Nutr Cancer Storz MA, Schmidt C, Ronco AL. PMID: 39370634 [PubMed - as supplied by publisher]
	A Nomogram for Predicting Suicide Risk and Prognostic Factors in Bladder Cancer Patients Following Diagnosis: More Information Needed. J Clin Nurs Li L, Ma X, Li Y. PMID: 39370538 [PubMed - as supplied by publisher]
	Development and validation of a clinic-radiomics model based on intratumoral habitat imaging for progression-free survival prediction of patients with clear cell renal cell carcinoma: A multicenter study. Urol Oncol Shan S, Sun HY, Yang Z, Li Q, Zhi R, Zhang YQ, Zhang YD. PMID: 39370309 [PubMed - as supplied by publisher]
	Single-Hit and Multi-hit PIK3CA Short Variant Genomic Alterations in Clinically Advanced Prostate Cancer: A Genomic Landscape Study. Target Oncol Basin MF, Miguel CM, Jacob JM, Goldberg H, Grivas P, Spiess PE, Necchi A, Kamat AM, Pavlick DC, Huang RSP, Lin DI, Danziger N, Sokol ES, Sivakumar S, Graf R, Cheng L, Vasan N, Ross J, Basnet A, Bratslavsky G. PMID: 39369133 [PubMed - as supplied by publisher]
	IG-Net: An Instrument-guided real-time semantic segmentation framework for prostate dissection during surgery for low rectal cancer. Comput Methods Programs Biomed Sun B, Sun Z, Li K, Wang X, Wang G, Song W, Li S, Hao A, Xiao Y. PMID: 39368441 [PubMed - as supplied by publisher]
	Evaluating response to radium-223 using (68)Ga-PSMA PET/CT imaging in patients with metastatic castration-resistant prostate cancer. Ann Nucl Med Shagera QA, Gil T, Barraco E, Boegner P, Kristanto P, El Ali Z, Sideris S, Martinez Chanza N, Roumeguère T, Flamen P, Artigas C. PMID: 39368051 [PubMed - as supplied by publisher]
	MRI software and cognitive fusion biopsies in people with suspected prostate cancer: a systematic review, network meta-analysis and cost-effectiveness analysis. Health Technol Assess Llewellyn A, Phung TH, O Soares M, Shepherd L, Glynn D, Harden M, Walker R, Duarte A, Dias S. PMID: 39367754 [PubMed - indexed for MEDLINE]
	Creatine supplementation does not add to resistance training effects in prostate cancer patients under androgen deprivation therapy: A double-blind randomized trial. J Sci Med Sport Fairman CM, Kendall KL, Newton RU, Hart NH, Taaffe DR, Lopez P, Chee R, Tang CI, Galvão DA. PMID: 39366880 [PubMed - as supplied by publisher]
	Health-related Quality of Life Assessment in Renal Cell Cancer: A Scoping Review. Eur Urol Oncol Gross F, Rasmussen IML, Beisland EG, Jorem GT, Beisland C, Pappot H, Arraras JI, Pe M, Holzner B, Wintner LM, EORTC Quality of Life Group. PMID: 39366818 [PubMed - as supplied by publisher]
	The Efficacy of Cabazitaxel in Treating Prostate Cancer: A Systematic Review and Meta-Analysis. Am J Mens Health Hashim HT, Khan MA, Shah SI, Al-Ghuraibawi MA, Sulaiman FA, Nasrallah J, Maroun R, Hashim AT, Ahmed N, Merza ZH. PMID: 39367721 [PubMed - indexed for MEDLINE]
	Multi-omics analysis unveils the predictive value of IGF2BP3/SPHK1 signaling in cancer stem cells for prognosis and immunotherapeutic response in muscle-invasive bladder cancer. J Transl Med Wang Y, Song W, Feng C, Wu S, Qin Z, Liu T, Ye Y, Huang R, Xie Y, Tang Z, Wang Q, Li T. PMID: 39367493 [PubMed - indexed for MEDLINE]
	Opposing impact of hypertension/diabetes following hormone therapy initiation and preexisting statins on castration resistant progression of nonmetastatic prostate cancer: a multicenter study. Sci Rep Hayashi T, Miyamoto T, Iwane S, Fujitani M, Uchitani K, Koizumi Y, Hirata A, Kinoshita H, Kawabata A. PMID: 39367145 [PubMed - indexed for MEDLINE]
	A genetic study to identify pathogenic mechanisms and drug targets for benign prostatic hyperplasia: a multi-omics Mendelian randomization study. Sci Rep Liu B, Wang X, Yang Z, Yin Z, Tang C, He Y, Ling Q, Huang Z, Feng S. PMID: 39367121 [PubMed - indexed for MEDLINE]

Artikel 1 - 20 / 171251

Seite 1 von 8563



		Zeitfenster

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Datenschutzerklärung / Privacy Policy \| Werbung